Core Insights - Lucid Diagnostics has formed a strategic partnership with VITALExam to enhance access to its EsoGuard® Esophageal DNA Test for firefighters at risk of esophageal precancer [1][2] - The partnership aims to drive revenue through fully-contracted CheckYourFoodTube Precancer Testing Events, starting with an event at Tuscaloosa Fire Rescue [1][2] - Firefighters face a 62% increased risk of developing esophageal cancer and a 39% increased risk of dying from it, highlighting the need for early detection [3] Company Overview - Lucid Diagnostics is a commercial-stage cancer prevention medical diagnostics company and a subsidiary of PAVmed Inc., focusing on patients with gastroesophageal reflux disease (GERD) who are at risk of esophageal precancer and cancer [4] - The EsoGuard® Esophageal DNA Test is the first and only commercially available tool designed for early detection of esophageal precancer in at-risk patients [4] Partnership Details - The partnership with VITALExam is expected to enhance the health of first responders by integrating EsoGuard into their wellness programs [2] - VITALExam provides comprehensive medical care for first responders, including cancer screenings and physical assessments, utilizing advanced technology [2]
Lucid Diagnostics Partners with VITALExam to Enhance Esophageal Precancer Detection for Firefighters